Anixa Biosciences Inc balance sheet

At the end of fiscal 2024, Anixa Biosciences Inc had total assets of $21.6m, total liabilities of $2.7m and shareholders' equity of $20.0m. It held $1.3m in cash against $0 of debt: net cash of $1.3m.

Balance sheet

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Anixa Biosciences Inc: balance sheet, annual
Fiscal year	2010Oct 2010	2011Oct 2011	2012Oct 2012	2013Oct 2013	2014Oct 2014	2015Oct 2015	2016Oct 2016	2017Oct 2017	2018Oct 2018	2019Oct 2019	2021Oct 2021	2023Oct 2023	2024Oct 2024
Cash and equivalents	1	1	0	1	3	4	2	3	3	3	29	1	1
Receivables	—	—	0	0	0	—	—	—	0	0	—	0	0
Inventory	0	—	—	—	—	—	—	—	—	—	—	—	—
Total current assets	1	3	1	1	6	7	3	7	6	6	36	25	21
Total assets	10	9	6	5	9	9	6	9	6	6	36	26	22
Accounts payable	0	0	0	1	1	0	0	0	1	1	0	0	1
Deferred revenue (current)	—	2	1	1	—	—	—	—	—	—	—	—	—
Total current liabilities	0	2	2	3	2	1	0	1	1	1	1	2	3
Long-term debt	—	—	—	—	—	0	—	—	—	—	—	—	—
Total debt	0	0	0	1	2	1	—	0	0	0	0	0	0
Total liabilities	—	—	—	9	5	4	5	1	—	1	1	2	3
Shareholders' equity	5	1	−1	−3	4	5	1	8	5	5	35	24	20
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	—	—	—	—	—	—	−0	—	−1	−1
Net debt (negative = net cash)	−1	−1	−0	−0	−1	−4	−2	−3	−3	−3	−29	−1	−1
Shares outstanding	154m	—	—	—	9m	9m	9m	—	19m	20m	30m	31m	32m

US$ millions unless shown otherwise. Fiscal quarters.

Anixa Biosciences Inc: balance sheet, quarterly
Quarter	2021 Q2Apr 2021	2021 Q3Jul 2021	2021 Q4Oct 2021	2022 Q1Jan 2022	2022 Q2Apr 2022	2023 Q2Apr 2023	2023 Q3Jul 2023	2023 Q4Oct 2023
Receivables	—	—	—	—	—	0	0	0
Total current assets	38	37	36	35	33	27	26	25
Total assets	38	37	36	35	33	28	27	26
Accounts payable	0	0	0	1	0	0	0	0
Total current liabilities	1	1	1	2	1	2	2	2
Total liabilities	—	—	1	2	1	2	2	2
Shareholders' equity	38	36	35	34	32	27	26	24
Non-controlling interests and other (assets − liabilities − equity)	—	—	—	−1	−1	−1	−1	−1
Shares outstanding	31m	30m	30m	30m	30m	31m	31m	31m

Balances at each fiscal year end (quarter end in the quarterly view). Total debt is short- plus long-term borrowings, including lease debt where the company reports it within debt. Where assets do not equal liabilities plus shareholders' equity, the difference (non-controlling interests, redeemable preferred shares) is shown on its own line.

Compare with peers

More: Biotechnology stocks compared, Health Care sector, rankings of US companies

Figures from Anixa Biosciences Inc's SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Anixa Biosciences Inc.